ClinicalTrials.Veeva

Menu

Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study

R

Region Örebro County

Status

Withdrawn

Conditions

Ventricular Tachycardia

Study type

Observational

Funder types

Other

Identifiers

NCT01947543
Protocol no: 2012-11

Details and patient eligibility

About

The aim of this study is to screen a well characterized patient population with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) for mutations in the calmodulin genes.

Full description

Patients with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) will be asked to participate in the study. For patients with results showing mutations in the calmodulin genes, family members (parents, siblings and children) will also be asked to participate in the study. For under age patients and relatives who agree to participate, informed consent will also be taken from their custodian.

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with ventricular tachycardia of unknown origin that have been treated with an ICD
  • Signed and dated informed consent

Exclusion criteria

  • Inability to provide informed consent

Trial design

0 participants in 2 patient groups

Ventricular tachycardia
Description:
Patients with ventricular tachycardia of unknown origin treated with an ICD.
Family members
Description:
Family members (parents, siblings and children) for patients with results showing mutations in the calmodulin genes.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems